Regeneron Pharmaceuticals【REGN】株式ニュース

名称	銘柄コード	市場	種別
Regeneron Pharmaceuticals Inc	REGN	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	14.31	1.48%	982.29	09:00:00

始値	安値	高値	終値	前日終値
969.27	966.00	982.77	982.29	967.98

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/18	06:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	05:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	05:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/18	02:45	GLOBE	More than $9 Million Awarded to High School Scientists and..
2024/5/16	07:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/15	05:21	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/13	14:00	GLOBE	Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review..
2024/5/08	19:00	GLOBE	Latest DB-OTO Results Show Dramatically Improved Hearing to..
2024/5/07	05:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/07	05:05	GLOBE	Regeneron Announces Investor Conference Presentations
2024/5/02	19:30	GLOBE	Regeneron Reports First Quarter 2024 Financial and Operating..
2024/4/29	20:00	GLOBE	EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO..
2024/4/25	20:00	GLOBE	Regeneron and Mammoth Biosciences Collaborate to Pursue..
2024/4/24	23:05	GLOBE	Regeneron to Showcase Progress in Advancing Novel..
2024/4/23	06:54	GLOBE	Regeneron to Highlight Advances in Genetic Medicine Research..
2024/4/16	20:18	IHMARKETNEWS	Ericsson Soars with 66% Net Profit Growth; Live Nation Under..
2024/4/11	20:24	IHMARKETNEWS	Costco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
2024/4/08	05:00	GLOBE	Linvoseltamab Pivotal Data Presented at AACR Reinforce High..
2024/4/02	05:05	GLOBE	Regeneron to Report First Quarter 2024 Financial and..
2024/3/25	20:00	GLOBE	Regeneron Provides Update on Biologics License Application..
2024/3/13	12:55	PRNUS	High School Seniors Win $1.8 Million at Regeneron Science..
2024/3/13	10:30	GLOBE	High School Seniors Win $1.8 Million at Regeneron Science..
2024/3/11	20:00	GLOBE	Praluent® (alirocumab) Injection Receives FDA Approval to..
2024/3/08	21:00	GLOBE	EYLEA® HD (aflibercept) Injection 8 mg Pivotal Data in Wet..
2024/3/06	06:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	06:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/02	06:14	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/29	06:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/29	06:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/29	06:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/27	06:34	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/27	06:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/27	06:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/27	06:07	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/27	06:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/27	05:25	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/24	06:04	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/23	15:00	GLOBE	Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review..
2024/2/23	07:10	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/23	06:06	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/21	21:00	GLOBE	Linvoseltamab BLA for Treatment of Relapsed/Refractory..
2024/2/21	06:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/17	06:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/16	14:59	GLOBE	Japan First in the World to Approve Dupixent® (dupilumab)..
2024/2/15	07:08	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/13	06:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/13	06:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/10	08:19	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/10	06:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/10	06:04	EDGAR2	Form 144 - Report of proposed sale of securities